tradingkey.logo

Incyte rises after co teases new research data for possible blood cancer treatment

ReutersJun 3, 2025 4:08 PM

Incyte INCY.O jumps 4% to $67.84 on Tues after the biopharma firm announced it will present new research data to support a potential treatment for blood cancer

INCY on track for biggest daily pct gain since Oct. 2024 and highest close in nearly three months

INCY said new research data from its "hematology/oncology" portfolio will be presented at the 2025 European Hematology Association (EHA) congress, held June 12 – 15 in Milan

Among 27 analysts that cover INCY, avg rating is "BUY" and median PT is $73

INCY remains down ~2% YTD vs ~4 drop in the S&P 500 health index .SPXHC

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI